Patents by Inventor Charronne Davis

Charronne Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quantitation and profiling of vaginal microflora
    Patent number: 9970060
    Abstract: Disclosed are methods of quantifying microflora in vaginal samples. Quantitative assessment of vaginal microflora by real-time PCR to create a profiling of Lactobacillus species, Gardnerella vaginalis, Atopobium vaginae, Megasphaera Type 1 and Type 2 and BVAB2 permits evaluation of bacterial vaginosis. Kits containing reagents for quantitative assessment of microflora are also disclosed.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: May 15, 2018
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Sergey Balashov, Martin E. Adelson, Charronne Davis
  • SINGLE NUCLEOTIDE POLYMORPHISMS AND USE OF SAME IN PREDICTING MALE-SPECIFIC PRENATAL LOSS
    Publication number: 20140045710
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.
    Type: Application
    Filed: February 12, 2013
    Publication date: February 13, 2014
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevik Dorak, Esma Ucisik-Akkaya, Charronne Davis, Thuy Ngoc Do
  • Single nucleotide polymorphisms and use of same predicting male-specific prenatal loss
    Patent number: 8394587
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: March 12, 2013
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevfik Dorak, Esma Ucisik-Akkaya, Charronne Davis, Thuy Ngoc Do
  • Single nucleotide polymorphisms as genetic markers for childhood leukemia
    Publication number: 20100092959
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific childhood leukemia risk. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk or a decreased risk for childhood leukemia for males and females is also disclosed.
    Type: Application
    Filed: June 3, 2009
    Publication date: April 15, 2010
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevfik Dorak, Esma Ucisik-Akkaya, Thuy Ngoc Do, Charronne Davis, Brittany Morrison
  • Single nucleotide polymorphisms and use of same predicting male- specific prenatal loss
    Publication number: 20100081135
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.
    Type: Application
    Filed: April 14, 2009
    Publication date: April 1, 2010
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevfik Dorak, Esma Ucisik-Akkaya, Charronne Davis, Thuy Ngoc Do